117 related articles for article (PubMed ID: 38101160)
41. Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer.
Huang WC; Chi HC; Tung SL; Chen PM; Shih YC; Huang YC; Chu PY
Cells; 2021 Sep; 10(10):. PubMed ID: 34685504
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
[TBL] [Abstract][Full Text] [Related]
43. In Silico and In Vivo Evaluation of microRNA-181c-5p's Role in Hepatocellular Carcinoma.
Abd ElAziz ON; Elfiky AM; Yassin MA; Abd El-Hakam FE; Saleh EM; El-Hefnawi M; Mohamed RH
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553610
[TBL] [Abstract][Full Text] [Related]
44. Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets‑1 network in triple-negative breast cancer.
Li W; Liu C; Zhao C; Zhai L; Lv S
Int J Oncol; 2016 Mar; 48(3):1155-64. PubMed ID: 26781040
[TBL] [Abstract][Full Text] [Related]
45. Genome-wide analysis reveals miR-3184-5p and miR-181c-3p as a critical regulator for adipocytes-associated breast cancer.
Rajarajan D; Selvarajan S; Charan Raja MR; Kar Mahapatra S; Kasiappan R
J Cell Physiol; 2019 Aug; 234(10):17959-17974. PubMed ID: 30847933
[TBL] [Abstract][Full Text] [Related]
46. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
47. Racial differences in RAD51 expression are regulated by miRNA-214-5P and its inhibition synergizes with olaparib in triple-negative breast cancer.
Mani C; Acharya G; Saamarthy K; Ochola D; Mereddy S; Pruitt K; Manne U; Palle K
Breast Cancer Res; 2023 Apr; 25(1):44. PubMed ID: 37081516
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-582-5p promotes triple-negative breast cancer invasion and metastasis by antagonizing CMTM8.
Zeng X; Ma X; Guo H; Wei L; Zhang Y; Sun C; Han N; Sun S; Zhang N
Bioengineered; 2021 Dec; 12(2):10126-10135. PubMed ID: 34978519
[TBL] [Abstract][Full Text] [Related]
49. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
Li J; Li Q; Lin L; Wang R; Chen L; Du W; Jiang C; Li R
BMC Neurol; 2018 Aug; 18(1):133. PubMed ID: 30170559
[TBL] [Abstract][Full Text] [Related]
50. miR-1207-5p regulates the sensitivity of triple-negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression.
Hou X; Niu Z; Liu L; Guo Q; Li H; Yang X; Zhang X
Oncol Lett; 2019 Jan; 17(1):990-998. PubMed ID: 30655858
[TBL] [Abstract][Full Text] [Related]
51. MiR-499b-5p inhibits cervical cancer cell proliferation and induces apoptosis by targeting the Notch1 signaling pathway.
Liu HM; Ji F; Lu Y; Chen SY
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6220-6231. PubMed ID: 34730202
[TBL] [Abstract][Full Text] [Related]
52. miR-589-5p Inhibits Cell Proliferation by Targeting Histone Deacetylase 3 in Triple Negative Breast Cancer.
Rahbari R; Rahimi K; Rasmi Y; Khadem-Ansari MH; Abdi M
Arch Med Res; 2022 Jul; 53(5):483-491. PubMed ID: 35840467
[TBL] [Abstract][Full Text] [Related]
53. LncRNA NEAT1 affects inflammatory response by targeting miR-129-5p and regulating Notch signaling pathway in epilepsy.
Wan Y; Yang ZQ
Cell Cycle; 2020 Feb; 19(4):419-431. PubMed ID: 31948324
[TBL] [Abstract][Full Text] [Related]
54. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
Liu Y; Cheng T; Du Y; Hu X; Xia W
BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
[TBL] [Abstract][Full Text] [Related]
55. LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production.
Nafea H; Youness RA; Abou-Aisha K; Gad MZ
J Cell Physiol; 2021 Jul; 236(7):5362-5372. PubMed ID: 33368266
[TBL] [Abstract][Full Text] [Related]
56. Long non-coding ribonucleic acid zinc finger E-box binding homeobox 1 antisense RNA 1 regulates myocardial fibrosis in diabetes through the Hippo-Yes-associated protein signaling pathway.
Wu J; Lyu R; Chen S; Wang X
J Diabetes Investig; 2023 Aug; 14(8):940-952. PubMed ID: 37309277
[TBL] [Abstract][Full Text] [Related]
57. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
[TBL] [Abstract][Full Text] [Related]
58. Long non-coding RNA SNHG8 enhances triple-negative breast cancer cell proliferation and migration by regulating the miR-335-5p/PYGO2 axis.
Qian J; Lei X; Sun Y; Zheng L; Li J; Zhang S; Zhang L; Li W; Shi J; Jia W; Tang T
Biol Direct; 2021 Aug; 16(1):13. PubMed ID: 34362407
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of MiR-181c-5p Attenuates Human Umbilical Vascular Endothelial Cell Injury in Deep Vein Thrombosis by Targeting FOS.
Yang F; Chen D; Liu Y; Zhang X; Su Y; Zhang X; Yin Z; Wu J
Int Heart J; 2023 Jul; 64(4):759-767. PubMed ID: 37460318
[TBL] [Abstract][Full Text] [Related]
60. Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway.
Wang LL; Huang WW; Huang J; Huang RF; Li NN; Hong Y; Chen ML; Wu F; Liu J
Kaohsiung J Med Sci; 2020 Aug; 36(8):581-591. PubMed ID: 32311203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]